Seroepidemiological assessment of the spread of SARS-CoV-2 among 25 and 28 year-old adult women in Finland between March 2020-June 2022
Rattachement africain : se, fi. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
INTRODUCTION: Serological surveys of the prevalence of SARS-CoV-2 are instrumental to understanding the course of the COVID-19 epidemic. We evaluate the seroprevalence of SARS-CoV-2 among young adult Finnish females residing in 25 communities all over Finland from 2020 until 2022. METHODS: Between 1st March 2020 and 30th June 2022, 3589 blood samples were collected from 3583 women born in 1992-95 when aged 25 or 28 years old attending the follow-up of an ongoing population-based trial of cervical screening strategies. The crude and population standardized SARS-CoV-2 seroprevalence was measured using nucleocapsid (induced by infection) and spike wild-type (WT) protein (induced both by infection and by vaccination) antigens over time and stratified by place of residence (inside or outside the Helsinki metropolitan region). RESULTS: During 2020 (before vaccinations), spike-WT and nucleocapsid IgG antibodies followed each other closely, at very low levels (<5%). Spike-WT seropositivity increased rapidly concomitant with mass vaccinations in 2021 and reached 96.3% in the 2nd quartile of 2022. Antibodies to nucleocapsid IgG remained relatively infrequent throughput 2020-2021, increasing rapidly in the 1st and 2nd quartiles of 2022 (to 19.7% and 56.6% respectively). The nucleocapsid IgG seropositivity increased more profoundly in participants residing in the Helsinki metropolitan region (4.5%, 8.4% and 43.9% in 2020, 2021 and 2022 respectively) compared to those residing in communities outside the capital region (4.5%, 4.3% and 34.7%). CONCLUSIONS: Low SARS-CoV-2 infection-related seroprevalence during 2020-2021 suggest a comparatively successful infection control. Antibodies to the SARS-CoV-2 WT spike protein became extremely common among young women by the end of 2021, in line with the high uptake of SARS-CoV-2 vaccination. Finally, the rapid increase of seroprevalences to the SARS-CoV-2 nucleocapsid protein during the first and second quartile of 2022, imply a high incidence of infections with SARS-CoV-2 variants able to escape vaccine-induced protection.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Seroepidemiological assessment of the spread of SARS-CoV-2 among 25 and 28 year-old adult women in Finland between March 2020-June 2022
- Date Crossref
- 11/07/2024
- Éditeur
- Public Library of Science (PLoS)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Karolinska Institutet pays non établi dans la noticeUniversité ou école supérieure
-
Tampere University Hospital pays non établi dans la noticeÉtablissement de santé
-
Tampere University pays non établi dans la noticeUniversité ou école supérieure
-
Science for Life Laboratory pays non établi dans la noticeStructure de recherche
-
KTH Royal Institute of Technology pays non établi dans la noticeUniversité ou école supérieure
-
Finnish Institute for Health and Welfare Department of Health Security pays non établi dans la noticeOrganisme public
-
Borealis (Finland) pays non établi dans la noticeEntreprise
-
Finland University pays non établi dans la noticeUniversité ou école supérieure
-
University of Oulu Biobank Borealis of Northern Finland pays non établi dans la noticeUniversité ou école supérieure
-
Department of Clinical Science Center for Cervical Cancer Elimination pays non établi dans la noticeÉtablissement de santé
-
Faculty of Medicine Unit of Population Health pays non établi dans la noticeUniversité ou école supérieure
Karolinska Institutet, Tampere University Hospital et Tampere University, avec 8 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.